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Protecting Health at Home & Abroad
CDC’s National Center for Emerging and Zoonotic Infectious 
Diseases (NCEZID) protects people in the United States and 
around the globe from emerging (new) and zoonotic (spread 
between people and animals) infectious diseases. NCEZID 
scientists save lives and protect Americans by reducing the 
spread of diseases like Ebola and Zika that cross borders 
and strengthen our country’s health security by focusing 
on pathogens that could be used in a bioterrorist event, 
like anthrax and plague. 
NCEZID ROLE IN 
GLOBAL HEALTH 
Lead major outbreak responses, providing 
the technical expertise and workforce for 
outbreaks like Ebola and Zika
Develop and deploy innovative and 
cost-effective technologies for global 
settings, leading to quicker diagnosis 
and earlier response
Strengthen public health systems to 
prevent global spread of disease, including 
robust surveillance and epidemiology, and 
responsive and effective laboratories
Reduce illness and death among U.S. 
travelers, expatriates and other globally 
mobile populations
Support country efforts to build infection 
control capacity and improve antibiotic use
NCEZID Around The World
Impact Highlights
Indonesia
ACTION:  
Detecting emerging viruses
 causing illness
Cameroon
ACTION:  
Improving local response 
to monkeypox
Ethiopia
ACTION:  
Prioritizing and preventing deadly 
zoonotic diseases that can affect 
US communities
Uganda
ACTION:  
Successful control of viral 
hemorrhagic fever (VHF) 
outbreaks (like Ebola)
Around 
the World
ACTION: 
Protecting Americans by developing 
guidelines for medical screening of 
people coming to live in the 
United States
India
ACTION:  
Combatting antimicrobial-
resistant germs that can 
cross borders
Brazil
ACTION:  
Conclusive evidence confirming a 
link between Zika and microcephaly 
during the early days of the 2015 
Zika virus epidemic
Sierra Leone
ACTION: 
Stronger infection control to prevent 
disease spread across borders
Indonesia
IMPACT: 
Indonesia is universally 
acknowledged as a likely hot spot 
for emerging, vector-borne viruses 
with pandemic potential.  In 2012, 
NCEZID began helping Indonesia 
build its first molecular laboratory 
for diagnosing emerging viruses, 
now one of the best in Southeast 
Asia. It made the first confirmations 
of West Nile and Zika viruses in the 
archipelago, alerting officials to 
potential outbreaks.  Now CDC and 
Indonesia are building a surveillance 
system around this new lab capacity 
to determine which vector-borne 
viruses are making people sick and 
stop them before disease spreads.
Cameroon
IMPACT: 
In 2016, NCEZID scientists trained 
their Cameroon colleagues 
to detect, test, and control 
monkeypox, caused by a virus in 
the same genus as the virus that 
causes smallpox. This training was 
applied a few months later when 
a serious outbreak of monkeypox 
surfaced among chimps at a 
primate conservation center. 
NCEZID deployed epidemiologists 
to assist Cameroon in their effective 
containment of the virus. Our 
recommendations led to better 
infection control to ensure that any 
future outbreaks are contained 
quickly and safely.
Ethiopia
IMPACT: 
In 2015, NCEZID facilitated a 
workshop in Ethiopia to assist 
government officials in prioritizing 
the 5 zoonotic diseases of greatest 
national concern. Using workshop 
results, Ethiopia is creating 
and implementing strategies 
to address the prioritized 
diseases and establishing proven 
prevention programs, such as 
vaccine programs. We continue to 
work with Ethiopia on prevention 
and control for these dangerous 
pathogens to ensure that future 
outbreaks are contained quickly 
before they cross borders.
Uganda
IMPACT: 
In 2010, NCEZID and partners 
established the first national viral 
hemorrhagic fever (VHF) surveillance 
and lab program in Uganda. This lab 
allows quicker testing so response 
teams can be deployed rapidly. In 
the 10 years prior to the program, 
only 3 VHF outbreaks were detected, 
with an average of 187 cases per 
outbreak. Since the program began, 10 
outbreaks, including Ebola, Marburg, 
Crimean-Congo hemorrhagic fever 
and Rift Valley fever, have been 
detected with an average of only 7 
cases per outbreak. This program 
has dramatically improved Uganda’s 
capacity to detect and respond to 
VHFs, reducing illness and saving lives.  
Around the World 
IMPACT: 
Medical screening for people 
before coming to live in the 
United States saves money and 
protects their health, and that of 
American communities. NCEZID 
develops the guidelines for the 
medical exams that are required 
for all US-bound immigrants 
and refugees.
India
IMPACT: 
NCEZID and India are laying the 
foundation for stopping the spread 
of antimicrobial resistance (AMR). 
In 2016, CDC helped expand national 
AMR surveillance to 13 labs in India 
and helped institutions within 
India measure AMR trends, prevent 
healthcare-associated infections, and 
improve antibiotic use. Data from 
the labs and networks will inform 
India’s national treatment guidelines, 
a critical step for combating AMR. 
These efforts lay the foundation for 
long-term, data-driven programs to 
stop the spread of AMR in India.
Brazil
IMPACT: 
NCEZID quickly developed two 
new tests that could detect Zika 
virus in tissues. In late 2015, tissue 
samples from two newborns who 
died within hours of birth and two 
miscarriages were submitted to 
CDC from Brazil. NCEZID scientists 
used the new tests to confirm 
the tissues were positive for Zika. 
This evidence led CDC to conclude 
that Zika causes microcephaly, 
and embark on critical research 
to protect pregnant women in the 
U.S. and around the world.
Sierra Leone
IMPACT: 
During the 2014 Ebola outbreak, 
NCEZID worked with Sierra Leone 
to fast-track development of a 
national program to decrease 
the spread of Ebola in healthcare 
facilities. The program’s success 
led Sierra Leone to bolster 25 
government hospitals and 14 
districts with trained infection 
prevention staff, ensuring that 
infection prevention and control 
remain a priority in healthcare.
Preparing for the Next Outbreak: NCEZID’s Role
Today, disease threats spread faster and more unpredictably than ever before. 
NCEZID experts are focused on preparing the U.S. and our global partners to 
respond to a range of potential threats. 
Combatting Global Antimicrobial Resistance
High levels of antimicrobial resistance (AMR) have been found in all regions 
of the world, threatening our ability to treat common infections. NCEZID is 
joining forces with world leaders, non-governmental organizations, private 
industry, and public health organizations to develop solutions to combat 
this urgent and growing threat. 
In 2016, CDC and NCEZID leadership met with world leaders at the United 
Nations General Assembly to reinforce the importance of global action to fight 
AMR and the threat it poses to development goals and modern medicine.  
NCEZID is working with federal and international partners to increase 
1) information exchange, 2) understanding of best approaches for use 
of antimicrobial drugs, and 3) prevention of healthcare and community 
associated drug-resistant infections.
NCEZID is also working to expand public health laboratory capacity to 
15 partner countries to identify priority pathogens with antimicrobial 
resistance and report results to international surveillance networks.
Developing New and Better Technologies 
Protecting Americans and people around the world demands that we 
develop and deploy better diagnostics, vaccines, and innovative prevention
solutions. Scientists responding to outbreaks abroad need faster and more 
accurate technologies, like those that use whole genome sequencing. The 
growing threat of vector-borne disease demands that we have tests that 
can distinguish between diseases with similar symptoms (like Zika, dengue, 
and chikungunya), but that require different treatments.
Prioritizing Zoonotic Diseases 
A One Health approach promotes multi-disciplinary collaboration across 
human, animal, and environmental health sectors to achieve optimal health 
outcomes for both people and animals. As an example, CDC’s One Health 
experts are working to globally implement a One Health Zoonotic Disease 
Prioritization process so that limited resources can be focused on those 
zoonotic diseases of greatest national concern. CDC scientists will assist 
these countries to develop effective control and prevention strategies to 
mitigate their greatest zoonotic disease threats.
The Aedes aegypti mosquito can spread Zika, dengue, 
chikungunya, and other viruses.
IMPROVING THE U.S. 
RESPONSE TO VECTOR-
BORNE DISEASE
Recent outbreaks of Zika, 
chikungunya, and dengue 
highlight the increasing threat 
of vector-borne disease to the 
U.S. and its territories from other 
parts of the world. CDC is at 
the forefront of developing a 
coordinated strategy to increase 
our understanding of these 
diseases, advance tools to combat 
vector-borne diseases, and 
help states prevent, detect, and 
respond to vector-borne threats.
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